Pharma Stocks

Pharmaceutical companies manufacture drugs that are used in medicines to cure illness ranging from cancer to a common cold. India has some of the world's largest pharmaceutical companies who have a strong reputation for mass producing generic drugs.

Innovation and Research Focus

Global Health Impact

Stable Revenue Streams

Regulatory Resilience

Get Started Live Share Market

List of Pharma Stocks

Pharma Stocks More Collections >

The Pharma Stocks collection features companies involved in the research, development, manufacturing, and distribution of pharmaceuticals. This sector is charac...Learn More

More Collections >

Filter

Reset Filter

Price

Market Cap

Last 1 Yr return

Analyst Recommendation

Dividend Yield

Index

Reset Filter

Apply

Name	Price	M Cap	Analyst Rating	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Div Yld	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Sun Pharmaceuticals Industries Ltd	₹1,520.00	Large Cap	BUY	1573.74	37.53%	58.08%	117.88%	278.44%	40.61	60.42	9.93	0.56	1.17%	2568.03 Cr	6.97%	151.36%	104.47%	12156.86	1.28%	13.53%	33.65%	19.51%	5.61%	121.4%	53%	Basic Materials	361471.81	13.89%	16.26%	35.68	1528417
Cipla Ltd	₹1,419.35	Large Cap	BUY	1458.38	21.42%	45.16%	48.17%	145.02%	26.23	60.42	2.95	0.23	0.94%	1068.51 Cr	-7.55%	10.78%	83.29%	6505.66	-1.27%	4.55%	32.81%	12.46%	-6.37%	5.97%	38.01%	Basic Materials	108154.59	10.66%	14.76%	35.13	5079900
Divis Laboratories Ltd	₹3,896.00	Large Cap	HOLD	3442.36	-9.67%	15.78%	-5.65%	133.42%	72.8	60.42	5.9	0.7	1.06%	358 Cr	2.87%	-38.41%	32.46%	1855	-2.83%	-13.31%	43.99%	23.47%	5.87%	-28.95%	-8.01%	Basic Materials	100705.51	14.82%	19.27%	68.69	276308
Zydus Lifesciences Ltd	₹995.40	Large Cap	BUY	844.61	66.44%	89.7%	59.14%	265.32%	33.43	60.42	3.65	0.54	1.22%	733.5 Cr	-5.94%	-56.32%	69.9%	4343.7	2%	14.08%	20.94%	11.59%	-7.78%	-61.71%	40.48%	Basic Materials	98827.27	11.38%	13.31%	19.74	1020698
Dr Reddys Laboratories Ltd	₹5,903.80	Large Cap	HOLD	6105.8	1.23%	31.04%	13.93%	111.26%	17.66	60.42	3.74	0.55	0.87%	1380.9 Cr	-6.83%	106.52%	122.47%	7214.8	4.86%	14.5%	40.83%	18.27%	-11.16%	80.36%	57.97%	Basic Materials	98773.1	13.46%	18.82%	270.55	296051
Mankind Pharma Ltd	₹2,190.30	Large Cap	BUY	2186.42	41.33%	61.51%	57.26%	57.26%	51.87	60.42	0	0.15	NA	459.81 Cr	-10.05%	-9.86%	24.01%	2606.96	-3.73%	12.44%	49.17%	14.97%	-6.56%	-19.83%	-16.87%	Pharmaceuticals	89601.62	17.43%	20.91%	0	250643
Torrent Pharmaceuticals Ltd	₹2,605.60	Mid Cap	BUY	2728.79	35.84%	56.05%	91.01%	215.36%	58.89	60.42	8.06	0.34	1.43%	443 Cr	14.77%	60.22%	21.52%	2691	2.4%	13.07%	21.17%	12.94%	12.08%	41.7%	0.29%	Basic Materials	87988.48	16.43%	17.68%	36.79	166700
Lupin Ltd	₹1,650.50	Mid Cap	HOLD	1546.91	94%	104.33%	36.5%	101.01%	38.24	60.42	1.6	0.39	0.62%	368.22 Cr	-40.48%	-129.66%	-265.95%	4895.11	-3.64%	1.44%	8.24%	2.69%	-38.24%	-129.24%	-253.31%	Basic Materials	73309.68	2.33%	3.21%	9.84	731048
Aurobindo Pharma Ltd	₹1,162.50	Mid Cap	BUY	1194.67	61.79%	83.74%	12%	57.22%	23.86	60.42	1.69	0.55	1.45%	939.97 Cr	25.01%	-27.18%	-32.21%	7271.23	1.69%	5.97%	7.61%	7.76%	22.93%	-31.28%	-37%	Basic Materials	66067.51	7.02%	8.39%	32.9	1091384
Alkem Laboratories Ltd	₹5,203.25	Mid Cap	HOLD	5184	22.61%	49.72%	71.36%	199.58%	38.98	60.42	4.34	0.61	1.47%	604.28 Cr	-1.73%	-40.08%	-12.4%	3323.87	-3.38%	9.08%	39.01%	8.68%	1.71%	-45.07%	-36.98%	Basic Materials	61323.69	12.54%	12.78%	84.22	137327
Abbott India Ltd	₹26,817.10	Mid Cap	BUY	27741.86	2.86%	24.23%	63.69%	262.04%	0	60.42	14.72	0.48	NA	0 Cr	0%	16.35%	0%	NA	0%	14.52%	0%	14.18%	0%	1.6%	0%	Basic Materials	56037.31	31.6%	39.94%	35.67	50453
Biocon Ltd	₹300.70	Mid Cap	HOLD	279.11	2.88%	22.61%	-21.81%	15.77%	30.28	60.42	2.27	1.12	0.73%	753.3 Cr	336.19%	-16.67%	-26.17%	3953.7	14.19%	36.54%	77.35%	5.75%	281.98%	-38.97%	-58.37%	Basic Materials	36498.24	-0.14%	1.5%	5.36	9534623

Why to invest in Pharma Stocks

Research and Development Focus: Pharma stocks are driven by a strong emphasis on research and development for the creation of innovative drugs.
Global Health Impact: Investing in pharma stocks aligns with contributing to global health and addressing medical challenges.
Stable Revenue Streams: These stocks often provide stable revenues due to consistent demand for medications and healthcare solutions.
Regulatory Resilience: Pharma stocks showcase resilience to regulatory changes, contributing to a stable investment environment.
Defensive Characteristics: Considered defensive, pharma stocks can offer stability during economic downturns.

Advantages of investing in Pharma Stocks

Pharma Stocks—an arena marked by innovation, demographic growth, and economic resilience. These investments thrive on breakthroughs, stable revenues, and alignment with global health trends, offering a compelling avenue for long-term growth in a dynamically evolving sector.

Innovation and Breakthroughs
Pharma stocks offer exposure to companies at the forefront of medical innovation, driving breakthrough treatments and advancements.
Demographic Tailwind
With a global aging population, pharma stocks benefit from increased healthcare needs, contributing to sustained demand for medications and healthcare solutions.
Defensive Characteristics
Considered defensive, pharma stocks exhibit stability during economic downturns, showcasing resilience in the face of market fluctuations.
Stable Revenue Streams
Many pharmaceutical companies enjoy stable revenue streams due to ongoing demand for essential medications and healthcare solutions.
Global Health Trends
Investing in pharma stocks aligns with addressing global health challenges, positioning these stocks for sustained long-term growth.
Regulatory Stability
Pharma stocks demonstrate resilience to regulatory changes, providing a stable investment environment for investors seeking predictability in the sector.

Who should consider investing in Pharma Stocks

For long-term stability, risk-averse investing, and a keen interest in innovation, Pharma Stocks present a compelling opportunity. Explore the potential for sustained growth in this dynamic sector, catering to those seeking reliability and advancements in medical research.

Long-Term Investors
Pharma stocks are suitable for long-term investors seeking stability, as the sector often realizes its full potential over extended periods.
Risk-Averse Individuals
Suited for risk-averse investors, pharma stocks exhibit defensive characteristics, providing stability even during market fluctuations.
Investors Interested in Innovation
Appealing to those interested in innovative advancements, pharma stocks provide exposure to companies driving breakthroughs in medical research and development.

Points to consider before investing in Pharma Stocks

As you delve into Pharma Stock investments, strategic considerations are crucial. Assess the regulatory framework, innovation pipeline, financial health, demographic trends, market positioning, and global health issues for informed and prudent decision-making in this dynamic sector.

Regulatory Environment
Assess the regulatory landscape affecting pharma stocks to understand potential impacts on operations and financials.
Pipeline of Innovation
Examine the innovation pipeline of pharma companies, assessing their potential for developing new drugs and medical technologies.
Financial Health
Thoroughly analyze the financial health of healthcare companies, considering factors like revenue growth, profitability, and debt levels.
Demographic Trends:
Consider demographic trends and their influence on healthcare needs, as an aging population often leads to increased demand for medical services.
Competition and Market Position
Evaluate the competitive landscape and market positioning of pharma stocks to identify companies with a strong foothold in the industry
Global Health Issues
Stay informed about global health issues, as they can significantly impact the demand for healthcare services and pharmaceuticals, influencing the performance of pharma stocks.

How to start investing in Pharma Stocks with INDmoney?

To buy Invest in Pharma Stocks from INDmoney, you will need to open a Demat account with them. Once you have opened a Demat account, you can follow these steps to buy Invest in Pharma Stocks:

Step 1
Complete KYC Process
Step 2
Invest in Pharma Stocks
Step 3
Choose for Intraday/Position

Should you invest in Invest in Pharma Stocks?

Investing in Pharma Stocks is prudent for those seeking stability, innovation, and exposure to a sector vital for global health. Evaluate your risk tolerance and embrace the potential for long-term growth in this resilient and dynamic landscape of pharmaceutical advancements.

Quick 5 Mins Course on Stock Market

Frequently Asked Questions

Pharma stocks represent publicly traded companies involved in researching, developing, manufacturing, and marketing pharmaceutical drugs and treatments. These companies play a vital role in advancing healthcare and stand to benefit from successful product launches and growing healthcare needs.

High R&D Costs: Developing new drugs is expensive and time-consuming, with a high risk of failure during clinical trials, potentially impacting stock prices.
Regulatory Hurdles: Strict government regulations can delay drug approvals, hindering a company's ability to bring products to market.
Patent Expiry: Once a drug's patent expires, generic competition can significantly reduce profitability.
Economic Downturns: Healthcare spending can be impacted by economic downturns, potentially affecting pharma companies' revenues

Strong R&D Pipeline: Look for companies with a robust pipeline of drugs in various stages of development.
Focus on Innovation: Companies prioritising innovative therapies or addressing unmet medical needs can be attractive.
Financials: Evaluate a company's financial health, considering factors like profitability, debt levels, and cash flow.
Regulatory Environment: Understanding the regulatory landscape in the company's target markets is crucial.

Explore Stocks Category: